BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Treatment
8015 results:

  • 1. Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Wu Y; Jiang P; Chen Z; Li W; Dong B; Zhang Y
    BMC Cancer; 2024 May; 24(1):589. PubMed ID: 38745137
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of myosteatosis and functionality in pretreatment gynecological cancer patients.
    da Silva RC; Chaves GV; Bergmann A; Frajacomo FTT
    Support Care Cancer; 2024 May; 32(6):339. PubMed ID: 38733544
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Vitamins in Gynecologic Malignancies.
    Wierzbowska N; Olszowski T; Chlubek D; Kozłowski M; Cymbaluk-Płoska A
    Nutrients; 2024 May; 16(9):. PubMed ID: 38732639
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
    BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
    J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
    J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Mooses K; Šavrova A; Pajusalu M; Oja M; Tamm S; Haug M; Padrik L; Laanpere M; Uusküla A; Kolde R
    Prev Med; 2024 Jun; 183():107982. PubMed ID: 38701952
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    Zhou Y; Wang W; Tang J; Hu K; Zhang F
    BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and Quantification of Radiotherapy-related Protein Expression in cancer Tissues Using the Qupath Software and Prediction of treatment Response.
    Hasegawa T; Someya M; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Okuda R; Kaguchi J; Ohguro A; Kamiyama R; Ashina A; Toshima Y; Hirohashi Y; Torigoe T; Sakata KI
    In Vivo; 2024; 38(3):1470-1476. PubMed ID: 38688633
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
    Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
    J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
    Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
    Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Huang K; Huang X; Zeng C; Wang S; Zhan Y; Cai Q; Peng G; Yang Z; Zhou L; Chen J; Chen C
    Cancer Imaging; 2024 Apr; 24(1):54. PubMed ID: 38654284
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]    [Full Text] [Related]  

  • 16. [Cognition of human papillomavirus and its influencing factors among college students in Shandong province].
    Zhang J; Shao SY; Ma YJ; Qin W
    Zhonghua Nan Ke Xue; 2023 Sep; 29(9):826-830. PubMed ID: 38639596
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
    Zeng Z; Zhu J; Wang Z; Wang G; Yan J; Zhang F
    Radiat Oncol; 2024 Apr; 19(1):48. PubMed ID: 38622628
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Reevaluation of negative cervical conizations: Frequency, diagnostic errors, risk factors and management.
    Lorenset LC; Percicote AP; Munhos SHO; Zanine RM
    Pathol Res Pract; 2024 May; 257():155283. PubMed ID: 38614053
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
    Oaknin A; Moore K; Meyer T; López-Picazo González J; Devriese LA; Amin A; Lao CD; Boni V; Sharfman WH; Park JC; Tahara M; Topalian SL; Magallanes M; Molina Alavez A; Khan TA; Copigneaux C; Lee M; Garnett-Benson C; Wang X; Naumann RW
    Lancet Oncol; 2024 May; 25(5):588-602. PubMed ID: 38608691
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 401.